Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Ambalal Sarabhai Enterprises Ltd (AMBALALSA) Share Price & Fundamentals

SegmentOfferingsAdvantages / MoatCustomersHigh-Margin AreasRevenue (₹ Cr.)Revenue %How We EarnPricing ModelGrowth DriversTop Brands
PharmaceuticalsManufacture and marketing of bulk drugs, oncology products, generics, vitamin C coated products, and niche APIs.Technical collaborations, regulatory certifications, established brand legacy, and specialized manufacturing capabilities.B2B pharmaceutical companies, healthcare providers, and international distributors.Oncology APIs and novel effervescent formulations.10855Revenue from direct sales to distributors, hospitals, and export clients.Transactional sales with contracts for supply; regulated pricing in certain markets.Growing demand for specialty oncology drugs, increased export orders, US FDA approvals.Asence Pharma, Sarabhai Chemicals, Suvik Hitek
ElectronicsManufacture and distribution of analytical instruments, test equipment, and professional audio-video products in India.Exclusive partnerships with international brands, extensive distribution network, and technical expertise.B2B clients like research institutions, broadcasters, and industrial labs.Analytical and test instruments segments.8845Sales of instruments and distribution services to various sectors including broadcast and research labs.Direct sales and distribution contracts.New product development, technological upgrades, and expanding distribution network across India.Systronics, Telerad

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions